Jim Cramer's Market Advice Ahead of Expected Pfizer Vaccine Rollout

The Food & Drug Administration is expected to grant Pfizer  (PFE) – Get Report and BioNTech  (BNTX) – Get Report an emergency use authorization for their vaccine. 

The FDA typically follows the committee’s decision, and it’s expected to roll out the vaccine possibly as soon as next week.

The committee’s recommendation to approve an emergency use authorization for the vaccine passed 17 to 4, with one abstention.

The administration is expected to grant the authorization for emergency use on Friday evening, The New York Times reported, citing people familiar with the agency’s planning.

WATCH: Everything Jim Cramer Is Watching in the Markets Friday

Latest Videos From TheStreet and Jim Cramer: